Do Insiders Own Shares In Omega Diagnostics Group PLC (LON:ODX)?

If you want to know who really controls Omega Diagnostics Group PLC (LON:ODX), then you'll have to look at the makeup of its share registry. Institutions will often hold stock in bigger companies, and we expect to see insiders owning a noticeable percentage of the smaller ones. I generally like to see some degree of insider ownership, even if only a little. As Nassim Nicholas Taleb said, 'Don’t tell me what you think, tell me what you have in your portfolio.

With a market capitalization of UK£23m, Omega Diagnostics Group is a small cap stock, so it might not be well known by many institutional investors. Taking a look at our data on the ownership groups (below), it's seems that institutions own shares in the company. Let's take a closer look to see what the different types of shareholder can tell us about Omega Diagnostics Group.

See our latest analysis for Omega Diagnostics Group

AIM:ODX Ownership Summary, January 24th 2020
AIM:ODX Ownership Summary, January 24th 2020
Advertisement

What Does The Institutional Ownership Tell Us About Omega Diagnostics Group?

Institutional investors commonly compare their own returns to the returns of a commonly followed index. So they generally do consider buying larger companies that are included in the relevant benchmark index.

Omega Diagnostics Group already has institutions on the share registry. Indeed, they own 50% of the company. This can indicate that the company has a certain degree of credibility in the investment community. However, it is best to be wary of relying on the supposed validation that comes with institutional investors. They too, get it wrong sometimes. If multiple institutions change their view on a stock at the same time, you could see the share price drop fast. It's therefore worth looking at Omega Diagnostics Group's earnings history, below. Of course, the future is what really matters.

AIM:ODX Income Statement, January 24th 2020
AIM:ODX Income Statement, January 24th 2020

Omega Diagnostics Group is not owned by hedge funds. The company's largest shareholder is Richard Sneller, with ownership of 25%, The second largest shareholder with 11%, is Legal & General Investment Management Limited, followed by Harwood Capital LLP, with an ownership of 9.0%.

A deeper analysis brings to light the fact that 54% of the company is controlled by the top 5 shareholders suggesting that these owners wield significant influence on the business.

Researching institutional ownership is a good way to gauge and filter a stock's expected performance. The same can be achieved by studying analyst sentiments. While there is some analyst coverage, the company is probably not widely covered. So it could gain more attention, down the track.

Insider Ownership Of Omega Diagnostics Group

The definition of an insider can differ slightly between different countries, but members of the board of directors always count. Management ultimately answers to the board. However, it is not uncommon for managers to be executive board members, especially if they are a founder or the CEO.

I generally consider insider ownership to be a good thing. However, on some occasions it makes it more difficult for other shareholders to hold the board accountable for decisions.

Our information suggests that insiders maintain a significant holding in Omega Diagnostics Group PLC. It has a market capitalization of just UK£23m, and insiders have UK£6.9m worth of shares in their own names. I would say this shows alignment with shareholders, but it is worth noting that the company is still quite small; some insiders may have founded the business. You can click here to see if those insiders have been buying or selling.

General Public Ownership

The general public holds a 10% stake in ODX. This size of ownership, while considerable, may not be enough to change company policy if the decision is not in sync with other large shareholders.

Private Equity Ownership

With an ownership of 11%, private equity firms are in a position to play a role in shaping corporate strategy with a focus on value creation. Sometimes we see private equity stick around for the long term, but generally speaking they have a shorter investment horizon and -- as the name suggests -- don't invest in public companies much. After some time they may look to sell and redeploy capital elsewhere.

Next Steps:

I find it very interesting to look at who exactly owns a company. But to truly gain insight, we need to consider other information, too. Take risks, for example - Omega Diagnostics Group has 2 warning signs we think you should be aware of.

But ultimately it is the future, not the past, that will determine how well the owners of this business will do. Therefore we think it advisable to take a look at this free report showing whether analysts are predicting a brighter future.

NB: Figures in this article are calculated using data from the last twelve months, which refer to the 12-month period ending on the last date of the month the financial statement is dated. This may not be consistent with full year annual report figures.

If you spot an error that warrants correction, please contact the editor at editorial-team@simplywallst.com. This article by Simply Wall St is general in nature. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Simply Wall St has no position in the stocks mentioned.

We aim to bring you long-term focused research analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Thank you for reading.

About AIM:CNSL

Cambridge Nutritional Sciences

Develops, manufactures, and distributes medical diagnostics products for the food sensitivity testing market.

Flawless balance sheet with proven track record.

Advertisement

Weekly Picks

LO
Lou_Basenese
CUE logo
Lou_Basenese on Cue Biopharma ·

Cue Biopharma (NASDAQ: CUE): The Scientist Behind Xolair Just Gave Cue a Next-Generation Shot at the Same Multi-Billion-Dollar Market

Fair Value:US$7058.5% undervalued
21 users have followed this narrative
0 users have commented on this narrative
5 users have liked this narrative
HA
HarishPK
ADBE logo
HarishPK on Adobe ·

Adobe: A Probabilistic Case for Undervaluation

Fair Value:US$317.222.8% undervalued
9 users have followed this narrative
4 users have commented on this narrative
6 users have liked this narrative
NI
niteco
AVGO logo
niteco on Broadcom ·

A Capital Allocation Favorite with Structural Importance

Fair Value:US$651.0539.1% undervalued
4 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
TO
Tokyo
OKTA logo
Tokyo on Okta ·

Good foundation, but now it's all about the next steps

Fair Value:US$15122.6% undervalued
82 users have followed this narrative
7 users have commented on this narrative
11 users have liked this narrative

Updated Narratives

TH
543931 logo
thepacific on Veefin Solutions ·

Undervalued, Underestimated

Fair Value:₹469.1533.1% undervalued
11 users have followed this narrative
1 users have commented on this narrative
0 users have liked this narrative
WA
TANCO logo
waioa on Tanco Holdings Berhad ·

Tanco's Pullback Brings Key Accumulation Zones Into Focus

Fair Value:RM 1.855.6% undervalued
2 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
AN
AntonioS
IEL logo
AntonioS on IDP Education ·

IDP Education Limited (ASX: IEL) - A contrarian Review

Fair Value:AU$4.6254.5% undervalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative

Popular Narratives

MA
martinarauz
NU logo
martinarauz on Nu Holdings ·

Investment Analysis (May 2026)

Fair Value:US$22.7449.0% undervalued
58 users have followed this narrative
0 users have commented on this narrative
15 users have liked this narrative
CL
Clive_Thompson
TTWO logo
Clive_Thompson on Take-Two Interactive Software ·

Take-Two Interactive: The Calm Before the Storm NASDAQ: TTWO Last Price: $242.41 Date: May 15, 2026

Fair Value:US$276.9723.3% undervalued
57 users have followed this narrative
0 users have commented on this narrative
14 users have liked this narrative
NI
niteco
HON logo
niteco on Honeywell International ·

Honeywell - The Demand-Side of the AI Infrastructure

Fair Value:US$320.1933.9% undervalued
48 users have followed this narrative
0 users have commented on this narrative
19 users have liked this narrative